相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type
Hironori Ninomiya et al.
LUNG CANCER (2009)
Gross cystic disease fluid protein - (GCDFP-15) expression in primary lung adenocarcinoma
Joan M. Striebel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Lung adenocarcinoma:: Modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis
Noriko Motoi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
The histopathology of BRAF-V600E-mutated lung adenocarcinoma
Samuel A. Yousem et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Micropapillary lung adenocarcinoma:: a distinctive histologic subtype with prognostic significance.: Case series
Nora Sanchez-Mora et al.
HUMAN PATHOLOGY (2008)
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib
Vincent A. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma
Kazunori Kamiya et al.
MODERN PATHOLOGY (2008)
Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factors
Takehito Kawakami et al.
MODERN PATHOLOGY (2007)
New insight into BRAF mutations in cancer
Nathalie Dhomen et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas
Vitor Trovisco et al.
HUMAN PATHOLOGY (2006)
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib
David M. Jackman et al.
CLINICAL CANCER RESEARCH (2006)
BRAF mutation predicts sensitivity to MEK inhibition
DB Solit et al.
NATURE (2006)
Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
H Shigematsu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
DA Eberhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Micropapillary pattern:: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (≤20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours)
Y Makimoto et al.
HISTOPATHOLOGY (2005)
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer
TY Chou et al.
CLINICAL CANCER RESEARCH (2005)
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer
F Cappuzzo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
EGFR mutation is specific for terminal respiratory unit type adenocarcinoma
Y Yatabe et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer
VA Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Relationship between micropapillary component and micrometastasis in the regional lymph nodes of patients with stage I lung adenocarcinoma
MS Roh et al.
HISTOPATHOLOGY (2004)
Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types
S Aida et al.
HISTOPATHOLOGY (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis
T Miyoshi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Micropapillary component in lung adenocarcinoma - A distinctive histologic feature with possible prognostic significance
MB Amin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Favorable and unfavorable morphological prognostic factors in peripheral adenocarcinoma of the lung 3 cm or less in diameter
T Yokose et al.
LUNG CANCER (2000)
分享论文
